GI & Endoscopy

A study in Hepatology found that the anti-inflammatory medication cromolyn sodium may be able to prevent liver disease, according to ScienceDaily.

The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab.

Bridgewater, N.J.-based Clinical Genomics, a biotechnology company focused on colorectal cancer diagnosis, has appointed four new hires to its leadership team.

AmSurg launched a program in March focused on improving patient safety during scope reprocessing. Here's what you need to know.

A study in BMC Medicine found that fecal microbiota transplantation is an effective long-term treatment for bacterial infection in the colon.

A study in American Journal of Gastroenterology found no increased risk of cancer for patients with elderly onset inflammatory bowel disease — however, there was evidence of increased risk for other oncology disorders.

The American Gastroenterological Association released a list of three policy areas that may be up for discussion following the 2016 election in November.

Here are four updates on gastroenterology and endoscopy companies.

A study in the American Journal of Gastroenterology found that pharmacy costs exceed inpatient care and outpatient care costs for patients with Crohn's disease.

Feza Remzi, MD, has been named the director of NYU Langone Medical Center's inflammatory bowel disease center in New York City.